RYALX
Price
$137.61
Change
-$1.87 (-1.34%)
Updated
Mar 5 closing price
Net Assets
16.74M
RYUHX
Price
$101.53
Change
-$1.12 (-1.09%)
Updated
Mar 5 closing price
Net Assets
38.83M
Ad is loading...

RYALX vs RYUHX

Header iconRYALX vs RYUHX Comparison
Open Charts RYALX vs RYUHXBanner chart's image
Rydex Inverse NASDAQ-100® Strategy H
Price$137.61
Change-$1.87 (-1.34%)
VolumeN/A
Net Assets16.74M
Rydex Inverse S&P 500® Strategy H
Price$101.53
Change-$1.12 (-1.09%)
VolumeN/A
Net Assets38.83M
RYALX vs RYUHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RYALX vs. RYUHX commentary
Mar 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYALX is a Hold and RYUHX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
RYUHX has more cash in the bank: 38.8M vs. RYALX (16.7M). RYALX pays higher dividends than RYUHX: RYALX (5.46) vs RYUHX (3.32). RYALX was incepted earlier than RYUHX: RYALX (10 years) vs RYUHX (10 years). RYALX (2500) and RYUHX (2500) have matching initial minimum investment requirements. RYUHX annual gain was more profitable for investors over the last year : -11.92 vs. RYALX (-12.90). RYUHX return over 5 years is better than : -57.03 vs. RYALX (-68.20).
RYALXRYUHXRYALX / RYUHX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence10 years10 years-
Gain YTD3.7802.650143%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets16.7M38.8M43%
Annual Yield % from dividends5.463.32164%
Returns for 1 year-12.90-11.92108%
Returns for 3 years-36.73-24.68149%
Returns for 5 years-68.20-57.03120%
Returns for 10 years-85.96-74.27116%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HDB60.320.62
+1.04%
HDFC Bank Limited
ARCB74.900.73
+0.98%
ArcBest Corp
OGE44.65-0.47
-1.04%
OGE Energy Corp
TRVI4.39-0.05
-1.13%
Trevi Therapeutics
IOBT0.90-0.01
-1.56%
IO Biotech